Argenta, the leading animal health pharmaceutical services company, today announced that it has closed on the carve-out acquisition of the manufacturing site and operations in Shawnee, Kansas, USA from TriRx Pharmaceuticals, LLC. As part of the Argenta platform, the world-class Shawnee facility will continue to operate as a leading provider of end-to-end CDMO services to the animal health industry. With a well-rounded set of capabilities including sterile fill-finish, non-sterile liquids and pastes, and oral solid dose – the site is ideally-positioned to continue growing with existing strategic customers as well as new potential clients who are looking for a reliable partner to help develop and manufacture their in-market portfolios and future pipeline products.
Read the full article: Argenta Acquires Shawnee Sterile Fill-Finish Manufacturing Site Dedicated to Animal Health //
Source: https://www.argentaglobal.com/post/argenta-acquires-shawnee-sterile-fill-finish-manufacturing